Body Composition and Adipose Tissue in HIV
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Body Composition and Adipose Tissue in HIV is a clinical trial[1].
Key Facts
- Body Composition and Adipose Tissue in HIV is in the country of United States[2].
- Body Composition and Adipose Tissue in HIV's instance of is recorded as clinical trial[3].
- Body Composition and Adipose Tissue in HIV's start time is recorded as +2018-02-07T00:00:00Z[4].
- Body Composition and Adipose Tissue in HIV's end time is recorded as +2021-04-30T00:00:00Z[5].
- Body Composition and Adipose Tissue in HIV's sponsor is recorded as Columbia University[6].
- Body Composition and Adipose Tissue in HIV's main subject is recorded as lipodystrophy[7].
- Body Composition and Adipose Tissue in HIV's number of participants is recorded as {'unit': '1', 'amount': '+24'}[8].
- Body Composition and Adipose Tissue in HIV's title is recorded as Body Composition and Adipose Tissue in HIV Lipodystrophy: Effects of Tesamorelin Therapy[9].
- Body Composition and Adipose Tissue in HIV's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[10].
- Body Composition and Adipose Tissue in HIV's ClinicalTrials.gov ID is recorded as NCT03226821[11].
- Body Composition and Adipose Tissue in HIV's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+68'}[12].
- Body Composition and Adipose Tissue in HIV's research intervention is recorded as tesamorelin[13].
- Body Composition and Adipose Tissue in HIV's clinical trial phase is recorded as phase IV clinical trial[14].
- Body Composition and Adipose Tissue in HIV's research subject recruitment status is recorded as recruiting[15].
- Body Composition and Adipose Tissue in HIV's study type is recorded as interventional study[16].